Volume 117, Issue 2, Pages (August 1999)

Slides:

Advertisements

Similar presentations

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Advertisements

Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Volume 117, Issue 2, Pages (August 1999)

Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F

The Role of Psychosocial Care in Adapting to Health Care Reform

Volume 126, Issue 1, Pages (January 2004)

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

Guillaume Bouguen, Barrett G. Levesque, Brian G

Nitsan Maharshak, Scott E. Plevy

Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy: Case Discussion and Review of the Literature Paul Y. Kwo, M.D., William J. Tremaine, M.D. Mayo.

Diagnosis of irritable bowel syndrome

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set Christopher.

Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol Peter A.L. Bonis, Marshall Kaplan

Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures Sunil Samuel, David H. Bruining,

Volume 130, Issue 4, Pages (April 2006)

Spreading and focusing of gluten epitopes in celiac disease

Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease

Appendectomy is followed by increased risk of Crohn's disease

Volume 135, Issue 5, Pages (November 2008)

Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease David H. Bruining, Edward.

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A

Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease Elana A. Maser, Renata Villela,

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Volume 130, Issue 2, Pages (February 2006)

Volume 120, Issue 4, Pages (March 2001)

Volume 123, Issue 2, Pages (August 2002)

Leflunomide as adjuvant treatment of dermatomyositis

A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab Fernando.

Population Health Management for Inflammatory Bowel Disease

Evidence of Endothelial Dysfunction in Patients With Inflammatory Bowel Disease Idan Roifman, Yichun C. Sun, Jason P. Fedwick, Remo Panaccione, Andre.

Volume 132, Issue 5, Pages (May 2007)

Volume 132, Issue 1, Pages (January 2007)

Volume 122, Issue 7, Pages (June 2002)

Covering the Cover Gastroenterology

David H. Bruining, William J. Sandborn

Volume 135, Issue 5, Pages (November 2008)

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

Prevention of Postoperative Recurrence in Crohn's Disease

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory.

Volume 121, Issue 5, Pages (November 2001)

Volume 124, Issue 4, Pages (April 2003)

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Siddharth.

Initiating Azathioprine for Crohn's Disease

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity Severine Vermeire, Stefan Schreiber,

Volume 119, Issue 4, Pages (October 2000)

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Volume 121, Issue 2, Pages (August 2001)

Volume 126, Issue 1, Pages (January 2004)

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease Jennifer Jones, Edward V. Loftus, Remo Panaccione,

AGA technical review on osteoporosis in gastrointestinal diseases

Volume 117, Issue 3, Pages (September 1999)

Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease William.

Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease Margien L. Seinen,

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Mesalamine and relapse prevention in Crohn's disease

Capsule Endoscopy for Refractory Iron Deficiency Anemia in Crohn’s Disease: Captivating Pathology, Hybrid Therapy Long Le, Brian M. Fung, James H. Tabibian

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease Guillaume Bouguen, Barrett G.

Gastroenterology Volume 124, Issue 4, (April 2003) DOI: /S (03)

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

A randomized trial of methotrexate versus azathioprine for severe atopic eczema Mandy Elvira Schram, MD, Evelien Roekevisch, MD, Mariska Maria Geertruida.

Predictors of response to infliximab in patients with Crohn's disease

Medical Therapy for Refractory Pediatric Crohn’s Disease

Volume 121, Issue 2, Pages (August 2001)

Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F

The Role of Psychosocial Care in Adapting to Health Care Reform

Covering the Cover Gastroenterology

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

Presentation transcript:

Volume 117, Issue 2, Pages 429-432 (August 1999) Successful management of Crohn's disease of the ileoanal pouch with infliximab Elena Ricart, Remo Panaccione, Edward V. Loftus, William J. Tremaine, William J. Sandborn Gastroenterology Volume 117, Issue 2, Pages 429-432 (August 1999) DOI: 10.1053/gast.1999.0029900429

1 Fig. 1. Course of CD within the pouch. Response and concurrent therapy. NR, no response; PR, partial response; CR, complete response; 2, clinical situation assessed by telephone call; ●, clinical visit; MTX, methotrexate; 6 MP, 6-mercaptopurine; Cipro, ciprofloxacin; AZA, azathioprine; Metro, metronidazole. Gastroenterology 1999 117, 429-432DOI: (10.1053/gast.1999.0029900429)